STXBP1 Gene Curation
Gene-disease assertions not curated here (add link or write note):
Disease | Developmental and epileptic encephalopathy 4 |
---|---|
Inheritance | Autosomal dominant |
Prevalence |
Source: |
Rapid or full curation? | Rapid Full |
ClinGen - Definitive | |
Clinical Validity Scoring Notes and points | ClinGen Epilepsy GCEP doesn’t provide a good summary, so will need to document molecular mechanism below.
|
Clinical Validity Points Total | n/a |
Clinical Validity Classification Definitive (12pts) Strong (12pts) Moderate (7-11pts) Limited (0.1-6pts) No genetic evidence Refuted Disputed | Definitive Source: ClinGen Epilepsy GCEP |
Molecular Mechanism Loss of function Gain of function Dominant negative Unknown Other | Loss of function
Review and natural history study cites LOF (can’t access the supplement) - PMID: 35851549
|
Penetrance Complete (100%) High (≥80%) Moderate (<80% and >20%) Low (≤20%) (list source/PMID) |
|
Age of Onset Congenital Pediatric Adolescent Adulthood Late adulthood (list source/PMID) | Early onset |
Severity | Severe |
Clinical Features | developmental and epileptic encephalopathy Epilepsy (tonic-clonic, focal, tonic seizures, epileptic spasms) Developmental delay, intellectual disability Autistic features Behavioral problems Gait disorders (postural abnormalities, broad-based gait, assymetric posture, dystonia) Movement disorders - ataxia, dystonia, dyskinesia, tremor, choreoathetosis) Tone abnormalities (spasticity, hypotonia 35851549, 27905812 |
HPO Terms |
|
Gene SOPs & Notes | LINK if SOP is a long document. Short notes if it is easy to digest. eg. Last known truncating variant |
Curation Summary | The STXBP1 gene is associated with autosomal dominant developmental and epileptic encephalopathy, which is characterized by epilepsy, developmental delay, intellectual disability, autistic features, behavioral problems, tone abnormalities (spasticity, hypotonia), and movement disorders (ataxia, dystonia, dyskinesia, tremor, choreoathetosis). The age of onset of seizures is typically in childhood with a median age of onset of 6 weeks (PMID: 26865513, 35851549, 27905812). Pathogenic variants are typically found to be de novo and the molecular mechanism is loss of function (PMID: 18703708, 31344879, 26384463). |
Case ID, Curator name, Date, Jira ticket link | Andrea Oza, SP0012515 2016-210-335, 08.19.2024 |